HOME Top Market Reports Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020

Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: December 2015
Report Code: MD 3960

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


Atrial Fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the globe. According to American Heart Association, around 33.5 million people were suffering from atrial fibrillation around the world in 2013. Furthermore, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S.

The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.

North America was the largest contributor (in terms of monetary value) in atrial fibrillation surgery market in 2014 and will continue to dominate this market by 2020. However, Asia-Pacific is expected to be the fastest growing market for the forecast period. Regulatory policies in Asia-Pacific countries are more adaptive and business-friendly, due to the presence of less-stringent regulations and data requirements. Additionally, increasing competition in mature markets will compel atrial fibrillation catheter ablation device manufacturers to focus on emerging markets in the coming years.

The increasing number of people suffering from atrial fibrillation is the major driving force for this market. Favorable regulations are supporting the increasing use of catheter and surgical ablation treatments for AF. Larger prevalence of atrial fibrillation and lower treatment cost would support the increasing number of atrial fibrillation surgical and catheter ablation procedures in countries like France.

The major players in this market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co.

Scope of the Report

This report talks about the following segments in this market:

Atrial Fibrillation Surgery Market, by Product

  • Catheter Ablation
  • Surgical Ablation

Atrial Fibrillation Surgery Procedures

  • Catheter Ablation
  • Surgical Ablation

Atrial Fibrillation Surgery Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAP
  • Rest of the World

Table of Content

1. Introduction
    1.1. Objectives of the Study
    1.2. Assumptions & Limitations

2. Research Methodology
    2.1. Atrial Fibrillation Catheter and Surgical Procedures
    2.2. Atrial Fibrillation Catheter and Surgical Ablation Market
    2.3. Forecasting Model
    2.4. Data Triangulation
    2.5. Primary Respondent Profile

3. Atrial Fibrillation Catheter and Surgical Procedure
    3.1. Overview
    3.2. Catheter Ablation Procedures
    3.3. Surgical Ablation/Maze Procedures

4. Atrial Fibrillation Surgery Product Market
    4.1. Overview
    4.2. Catheter Ablation Product Market
    4.3. Surgical Ablation Market

5. Competitive Landscape
    5.1. Market Share Analysis: Af Catheter Ablation Market, 2014
    5.2. Market Share Analysis: Af Surgical Ablation Market, 2014
    5.3. Competitive Landscape

6. Company Profiles (Business Overview, Company at Glance, Financials, Geographic Revenue Mix, Business Revenue Mix, Product Portfolio, Key Strategies, Recent Developments)
    6.1. Biosense Webster, Inc.
    6.2. Medtronic, Inc.
    6.3. St. Jude Medical, Inc.
    6.4. Boston Scientific Corporation
    6.5. Atricure, Inc.
    6.6. Cardiofocus, Inc.
    6.7. Ncontact, Inc.
    6.8. Carima, Inc.
    6.9. Biotroik Se & Co.Kg

7. Appendix
    7.1. Additional Insights
    7.2. Secondary Resources
    7.3. Related Reports


List of Tables (18 Tables)

Table 1 Atrial Fibrillation Surgical Procedures, By Type of Procedure (Number of Procedures)
Table 2 Atrial Fibrillation Catheter Ablation Procedures, By Region (Number of Procedures)
Table 3 North America: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 4 Europe: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 5 Asia-Pacific: Atrial Fibrillation Catheter Ablation Procedures, By Country (Number of Procedures)
Table 6 Atrial Fibrillation Surgical Ablation/Maze Procedures, By Region (Number of Procedures)
Table 7 North America: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 8 Europe: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 9 Asia-Pacific: Atrial Fibrillation Surgical Ablation/Maze Procedures, By Country (Number of Procedures)
Table 10 Atrial Fibrillation Surgery Product Market, By Type of Procedure ($ Million)
Table 11 Global Atrial Fibrillation Catheter Ablation Product Market, By Region ($ Million)
Table 12 North America: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 13 Europe: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 14 Asia-Pacific: Atrial Fibrillation Catheter Ablation Product Market, By Country ($ Million)
Table 15 Atrial Fibrillation Surgical Ablation Product Market, By Region ($ Million)
Table 16 North America: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)
Table 17 Europe: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)
Table 18 Asia-Pacific: Atrial Fibrillation Surgical Ablation Product Market, By Country ($ Million)

Atrial fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart rhythm. Increasing prevalence of atrial fibrillation has been observed across the globe. According to American Heart Association, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S. The major factor driving this market is the increasing number of people suffering from atrial fibrillation. Favorable regulatory scenario would also propel growth in this market.

On the basis of surgical procedures this market is segmented into catheter ablation and surgical ablation. Catheter ablation procedures hold the major share in this market and are expected to grow with the highest CAGR during the forecast period of 2015 to 2020. Nevertheless, surgical ablation market is also expected to have a growth rate close to catheter ablation during the forecast period. The development in the surgical ablation technology and better results of these procedures are driving the overall number of surgical ablation procedures.

On the basis of geography, this market is segmented into: North America, Europe, Asia-Pacific and RoW. North America held the largest share in this market in 2014 and is expected to grow with the highest CAGR, including the number of procedures and revenue. On the other hand, Asia-Pacific is expected to be the fastest growing region due to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.

The major players in this market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co. As of 2014, the atrial fibrillation catheter ablation market was highly consolidated with top 4 companies dominating the entire market. The market was dominated by Biosense Webster, Inc., a J&J company (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic, Inc. (U.S.), and Boston Scientific Corporation (U.S.).

Atrial Fibrillation Surgery Market

Available Customizations Title

Client Consult Problem Statement : MnM’s Client, (a leading player in surgery market) was interested in understanding the atrial fibrillation market with a focus on market sizing of surgery products at a global level, broken down into catheter and surgical ablation. Client was also interested in the number of procedures performed for each of the ablation procedure type. Competitive landscape covered market share of major companies in AF catheter ablation and surgical ablation products, along with major developments at global level.

Solution Provided:

1. Methodology Adopted by MnM :

MnM carried out this study through a combinatio....

1. Methodology Adopted by MnM :

MnM carried out this study through a combination of extensive secondary research followed by primary discussions with Key Opinion Leaders across the value chains within target geographies. Both, top-down and bottom-up approaches were used to cover key sources of primary information that supply and demand sides with their channel partners & associates, along with current market players into the AF surgery market and other industry experts. By conducting detailed and informative primary discussions within these respondent categories across various functions, MnM analyzed current & forecast quantitative market information, and developed deep-dive qualitative insights into industry trends & dynamics across each of the target countries. In total, MnM conducted 100 primary discussions, of which 30 were within the supplier segment, while balance 70 spanned across covering end-user segments like the doctors and medical institutes, local government & medical associations and other industry experts.

2. Actual Solution Provided:

   • MnM studied the value and supply chain processes in various regions across the globe capturing product portfolio of several companies.
   • The study also estimates the market size by catheter and surgical ablation processes.
   • Average procedures conducted for catheter and surgical ablation were estimated for the major geographies
   • Competitive profiling for major companies in the existing portfolio for atrial fibrillation market
   • Recent developments and regulatory scenarios in the existing market

Value Delivered:

Through the detailed outcome of the study, MnM’s client was able to assess intrinsic market insights for its product in atrial fibrillation market. The granular set of information and recommendations shared by MnM assisted the client to expand its business across newer and untapped growth markets and restructuring current network by establishing a good hold and capturing the major markets. These strategic changes by MnM’s client resulted in its business expansion and revenue growth.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Cardiovascular Devices Markets on KnowledgeStore
Request Demo